Pricing Log in Create free account

Intensity Therapeutics Inc. (INTS) vs Kiora Pharmaceuticals, Inc. (KPRX)

Intensity Therapeutics Inc. and Kiora Pharmaceuticals, Inc. are both Biotechnology companies. Intensity Therapeutics Inc. and Kiora Pharmaceuticals, Inc. are of similar size ($11.0M and $10.7M). Across the 12 metrics below, Kiora Pharmaceuticals, Inc. leads on 7 and Intensity Therapeutics Inc. on 5.

Valuation

Metric INTS KPRX Biotechnology median
P/E n/m n/m 8.50
P/S n/m 0.79 9.71
P/B 0.98 0.88 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.03 0.15 0.64
EV/Sales n/m (0.10) 9.21
Earnings yield (50.85%) (103.07%) (33.15%)
Free cash flow yield (98.74%) (58.10%) (25.50%)

Profitability

Metric INTS KPRX Biotechnology median
Gross margin 0.00% 85.06% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (195.88%) (56.36%) (56.36%)
Return on assets (139.85%) (39.43%) (48.04%)
Return on invested capital 0.00% (44,053.91%) 0.00%

Growth

Metric INTS KPRX Biotechnology median
Revenue growth (TTM) — 983.73% 6.02%
EPS growth (last fiscal year) 70.74% (403.45%) 30.26%
Revenue growth, 5-year CAGR — 88.72% 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric INTS KPRX Biotechnology median
Debt to equity 0.01 0.00 0.00
Current ratio 5.00 8.97 4.72
Net debt to EBITDA 0.99 1.33 0.96

Dividend

Metric INTS KPRX Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric INTS KPRX Biotechnology median
Market cap 11.04m 10.66m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack